Table 2.

Logistic analysis for the individual cancer group adjusted for age and sex

Cancer groups (NORDCAN)	p Value	OR (95% CI)
Pancreas	0.184	1.50 (0.83 to 2.72)
Brain/CNS	0.159	0.66 (0.38 to 1.16)
Cervix uteri	0.503	1.18 (0.73 to 1.94)
Leukaemia	0.233	0.73 (0.43 to 1.23)
Lip, oral cavity and pharynx	0.496	1.18 (0.73 to 1.92)
Corpus uteri	0.797	1.06 (0.69 to 1.62)
Rectum and anus	0.470	0.85 (0.55 to 1.31)
Melanoma of skin	0.262	0.79 (0.51 to 1.20)
Prostate	0.455	1.16 (0.78 to 1.73)
Colon	0.215	0.78 (0.53 to 1.15)
Bladder, etc	0.039	1.44 (1.02 to 2.05)
Lung	0.720	1.06 (0.78 to 1.43)
Colorectal	0.187	0.82 (0.61 to 1.10)
Breast	0.031	0.80 (0.65 to 0.98)
Skin, non-melanoma	0.020	0.82 (0.70 to 0.97)
All sites but non-melanoma skin cancer	0.415	0.96 (0.86 to 1.06)
Final logistic analysis
Bladder, etc	0.040	1.44 (1.02 to 2.05)
Breast	0.035	0.80 (0.65 to 0.98)
Skin, non-melanoma	0.021	0.83 (0.70 to 0.97)
Brain/CNS	0.513	1.35 (0.55 to 3.33)
Brain/CNS×sex	0.080	0.36 (0.12 to 1.13)

The last six rows are the final analysis outcome with the interaction variable and the significant cancer groups. CNS, central nervous system.